217 related articles for article (PubMed ID: 28554259)
1. Frequency and prognostic significance of additional cytogenetic abnormalities to the Philadelphia chromosome in young and older adults with acute lymphoblastic leukemia.
Motlló C; Ribera JM; Morgades M; Granada I; Montesinos P; Mercadal S; González-Campos J; Moreno MJ; Barba P; Cervera M; Barrios M; Novo A; Bernal T; Hernández-Rivas JM; Abella E; Amigo ML; Tormo M; Martino R; Lavilla E; Bergua J; Serrano A; García-Belmonte D; Guàrdia R; Grau J; Feliu E;
Leuk Lymphoma; 2018 Jan; 59(1):146-154. PubMed ID: 28554259
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of recurrent additional chromosomal abnormalities in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Seol CA; Cho YU; Jang S; Park CJ; Lee JH; Lee JH; Lee KH; Seo EJ
Cancer Genet; 2017 Oct; 216-217():29-36. PubMed ID: 29025593
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
[TBL] [Abstract][Full Text] [Related]
4. Cytogenetic abnormalities in adult acute lymphoblastic leukemia: correlations with hematologic findings outcome. A Collaborative Study of the Group Français de Cytogénétique Hématologique.
Blood; 1996 Apr; 87(8):3135-42. PubMed ID: 8605327
[TBL] [Abstract][Full Text] [Related]
5. Structure and significance of cytogenetic abnormalities in adult patients with Ph-negative acute lymphoblastic leukemia.
Piskunova IS; Obukhova TN; Parovichnikova EN; Kulikov SM; Troitskaya VV; Gavrilina OA; Savchenko VG
Ter Arkh; 2018 Aug; 90(7):30-37. PubMed ID: 30701920
[TBL] [Abstract][Full Text] [Related]
6. Impact of Additional Cytogenetic Abnormalities in Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation.
Aldoss I; Stiller T; Cao TM; Palmer JM; Thomas SH; Forman SJ; Pullarkat V
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1326-9. PubMed ID: 25842050
[TBL] [Abstract][Full Text] [Related]
7. Philadelphia positive acute lymphoblastic leukemia in adults: age distribution, BCR breakpoint and prognostic significance.
Secker-Walker LM; Craig JM; Hawkins JM; Hoffbrand AV
Leukemia; 1991 Mar; 5(3):196-9. PubMed ID: 2013979
[TBL] [Abstract][Full Text] [Related]
8. Clonal evolution detected with conventional cytogenetic analysis is a potent prognostic factor in adult patients with relapsed Philadelphia chromosome-negative acute lymphoblastic leukemia.
Shimizu H; Yokohama A; Ishizaki T; Hatsumi N; Takada S; Saitoh T; Sakura T; Handa H
Leuk Res; 2021 Apr; 103():106535. PubMed ID: 33611095
[TBL] [Abstract][Full Text] [Related]
9. Monosomal karyotype is associated with poor outcomes in patients with Philadelphia chromosome-negative acute lymphoblastic leukemia receiving chemotherapy but not allogeneic hematopoietic stem cell transplantation.
Li Z; Lai Y; Zhang X; Xu L; Liu K; Wang Y; Yan C; Jiang H; Huang X; Jiang Q
Ann Hematol; 2020 Aug; 99(8):1833-1843. PubMed ID: 32577842
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of complex karyotype and monosomal karyotype in adult patients with acute lymphoblastic leukemia treated with risk-adapted protocols.
Motlló C; Ribera JM; Morgades M; Granada I; Montesinos P; González-Campos J; Fernández-Abellán P; Tormo M; Bethencourt C; Brunet S; Hernández-Rivas JM; Moreno MJ; Sarrà J; Del Potro E; Barba P; Bernal T; Grande C; Grau J; Cervera J; Feliu E;
Cancer; 2014 Dec; 120(24):3958-64. PubMed ID: 25116331
[TBL] [Abstract][Full Text] [Related]
11. Monosomal karyotype is not a predictor of dismal outcome in childhood de novo acute myeloid leukemia.
Lee NH; Choi YB; Yi ES; Lee SH; Kim HJ; Lee JW; Sung KW; Koo HH; Yoo KH
Leuk Res; 2016 Nov; 50():57-62. PubMed ID: 27683973
[TBL] [Abstract][Full Text] [Related]
12. [Clinical study of Philadelphia chromosome-positive adult acute lymphoblastic leukemia].
Zhang YF; Chen ZM; Lou JY; Ni WM; Wang YG; Meng HT; Tong HY; Qian WB; Jin J
Zhonghua Xue Ye Xue Za Zhi; 2011 Dec; 32(12):814-8. PubMed ID: 22339953
[TBL] [Abstract][Full Text] [Related]
13. Additional Cytogenetic Abnormalities with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia on Allogeneic Stem Cell Transplantation in the Tyrosine Kinase Inhibitor Era.
Akahoshi Y; Mizuta S; Shimizu H; Uchida N; Fukuda T; Kanamori H; Onizuka M; Ozawa Y; Ohashi K; Ohta S; Eto T; Tanaka J; Atsuta Y; Kako S;
Biol Blood Marrow Transplant; 2018 Oct; 24(10):2009-2016. PubMed ID: 29908230
[TBL] [Abstract][Full Text] [Related]
14. Outcome of treatment in adults with Philadelphia chromosome-positive and/or BCR-ABL--positive acute lymphoblastic leukemia-retrospective analysis of Polish Adult Leukemia Group (PALG).
Wrzesień-Kuś A; Robak T; Pluta A; Zwolińska M; Wawrzyniak E; Wierzbowska A; Skotnicki A; Jakubas B; Hołowiecki J; Nowak K; Kuliczkowski K; Mazur G; Haus O; Dmoszyńska A; Adamczyk-Cioch M; Jedrzejczak WW; Paluszewska M; Konopka L; Pałynyczko G
Ann Hematol; 2006 Jun; 85(6):366-73. PubMed ID: 16523310
[TBL] [Abstract][Full Text] [Related]
15. Poor outcomes associated with +der(22)t(9;22) and -9/9p in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia receiving chemotherapy plus a tyrosine kinase inhibitor.
Short NJ; Kantarjian HM; Sasaki K; Ravandi F; Ko H; Cameron Yin C; Garcia-Manero G; Cortes JE; Garris R; O'Brien SM; Patel K; Khouri M; Thomas D; Jain N; Kadia TM; Daver NG; Benton CB; Issa GC; Konopleva M; Jabbour E
Am J Hematol; 2017 Mar; 92(3):238-243. PubMed ID: 28006851
[TBL] [Abstract][Full Text] [Related]
16. Secondary cytogenetic aberrations in childhood Philadelphia chromosome positive acute lymphoblastic leukemia are nonrandom and may be associated with outcome.
Heerema NA; Harbott J; Galimberti S; Camitta BM; Gaynon PS; Janka-Schaub G; Kamps W; Basso G; Pui CH; Schrappe M; Auclerc MF; Carroll AJ; Conter V; Harrison CJ; Pullen J; Raimondi SC; Richards S; Riehm H; Sather HN; Shuster JJ; Silverman LB; Valsecchi MG; Aricò M; ; ; ; ; ; ; ; ; ; ;
Leukemia; 2004 Apr; 18(4):693-702. PubMed ID: 15044926
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and prognostic factors of imatinib plus CALLG2008 protocol in adult patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.
Lou Y; Ma Y; Li C; Suo S; Tong H; Qian W; Mai W; Meng H; Yu W; Mao L; Wei J; Xu W; Jin J
Front Med; 2017 Jun; 11(2):229-238. PubMed ID: 28349299
[TBL] [Abstract][Full Text] [Related]
18. Molecular diagnosis and clinical relevance of t(9;22), t(4;11) and t(1 ;19) chromosome abnormalities in a consecutive group of 141 adult patients with acute lymphoblastic leukemia.
Rambaldi A; Attuati V; Bassan R; Neonato MG; Viero P; Battista R; Di Bona E; Rossi G; Pogliani E; Ruggeri M; Amaru R; Rivolta A; Giudici G; Biondi A; Barbui T
Leuk Lymphoma; 1996 May; 21(5-6):457-66. PubMed ID: 9172811
[TBL] [Abstract][Full Text] [Related]
19. Outcome of Philadelphia chromosome-positive adult acute lymphoblastic leukemia.
Faderl S; Kantarjian HM; Thomas DA; Cortes J; Giles F; Pierce S; Albitar M; Estrov Z
Leuk Lymphoma; 2000 Jan; 36(3-4):263-73. PubMed ID: 10674898
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of persistent cytogenetic abnormalities at complete remission in adult patients with acute lymphoblastic leukemia.
Short NJ; Kantarjian HM; Jabbour EJ; O'Brien SM; Faderl S; Burger JA; Garris R; Qiao W; Huang X; Jain N; Konopleva M; Kadia TM; Daver N; Borthakur G; Cortes JE; Ravandi F
Am J Hematol; 2016 Jun; 91(4):385-9. PubMed ID: 26800008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
